Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis : Can we safely reduce the dose of administered agents?AAPRO, Matti ; BLOWER, PeterCancer, 2005-07, Vol.104 (1), p.1-13 [Periódico revisado por pares]New York, NY: Wiley-LissTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti‐di‐diethylenetriaminepentaacetic acid F(ab′)2 antibodyAarts, Frits ; Boerman, Otto C. ; Sharkey, Robert M. ; Hendriks, Thijs ; Chang, Chien‐Hsing ; McBride, William J. ; Bleichrodt, Robert P. ; Oyen, Wim J. G. ; Goldenberg, David M.Cancer, 2010-02, Vol.116 (S4), p.1111-1117 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Sequential methotrexate, 5‐fluorouracil (5‐FU), and high dose leucovorin versus 5‐FU and high dose leucovorin versus 5‐FU alone for advanced colorectal cancer. A multi‐institutional randomized trialAbad, Albert ; Garcia, Pilar ; Gravalos, Cristina ; Tusquets, Ignaci ; Font, Albert ; Perez, Gumersindo ; Cortés‐Funes, Hernán ; Fabregat, Dd Xavier ; Barnadas, Agustí ; Rosell, RafaelCancer, 1995-03, Vol.75 (6), p.1238-1244 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Cost‐effectiveness analysis of oxaliplatin compared with 5‐fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the USAballéa, Samuel ; Chancellor, Jeremy V.M. ; Raikou, Maria ; Drummond, Michael F. ; Weinstein, Milton C. ; Jourdan, Sophia ; Bridgewater, JohnCancer, 2007-03, Vol.109 (6), p.1082-1089 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignanciesAbaza, Yasmin M. ; Kadia, Tapan M. ; Jabbour, Elias J. ; Konopleva, Marina Y. ; Borthakur, Gautam ; Ferrajoli, Alessandra ; Estrov, Zeev ; Wierda, William G. ; Alfonso, Ana ; Chong, Toh Han ; Chuah, Charles ; Koh, Liang‐Piu ; Goh, Boon‐Cher ; Chang, Julie E. ; Durkes, Daniel E. ; Foudray, Maria Cielo ; Kantarjian, Hagop M. ; Dong, Xiao Qin ; Garcia‐Manero, GuillermoCancer, 2017-12, Vol.123 (24), p.4851-4859 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Cationic polymer‐mediated small interfering RNA delivery for P‐glycoprotein down‐regulation in tumor cellsAbbasi, Meysam ; Lavasanifar, Afsaneh ; Berthiaume, Luc G. ; Weinfeld, Michael ; Uludağ, HasanCancer, 2010-12, Vol.116 (23), p.5544-5554 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United StatesAbbott, Andrea M. ; Habermann, Elizabeth B. ; Tuttle, Todd M.Cancer, 2011-08, Vol.117 (15), p.3305-3310 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Operative treatment of colorectal cancerAbcarian, HerandCancer, 1992-09, Vol.70 (S3), p.1350-1354 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcomaAbdeen, Ayesha ; Chou, Alexander J. ; Healey, John H. ; Khanna, Chand ; Osborne, Tanasa S. ; Hewitt, Stephen M. ; Kim, Mimi ; Wang, Dan ; Moody, Karen ; Gorlick, RichardCancer, 2009-11, Vol.115 (22), p.5243-5250 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A Phase I clinical trial of immunotherapy with interferon-γ gene-modified autologous melanoma cells : Monitoring the humoral immune responseABDEL-WAHAB, Z ; WELTZ, C ; HESTER, D ; PICKETT, N ; VERVAERT, C ; BARBER, J. R ; JOLLY, D ; SEIGLER, H. FCancer, 1997-08, Vol.80 (3), p.401-412 [Periódico revisado por pares]New York, NY: Wiley-LissTexto completo disponível |